Skip to content

Drug interactions

Elvitegravir / cobicistat / emtricitabine / tenofovir df + Ropivacaine

Severity: Moderate

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Ropivacaine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ropivacaine is metabolized partly by CYP3A4 and CYP1A2, and cobicistat inhibits CYP3A4. Plasma levels may rise modestly, increasing the potential for local anesthetic toxicity with prolonged infusions.

What this interaction means in plain words

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Ropivacaine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Cobicistat inhibition of CYP3A4-mediated ropivacaine metabolism.

What to do

Avoid prolonged ropivacaine infusions where possible, or reduce the dose and monitor for neurologic and cardiac signs of local anesthetic toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir / cobicistat / emtricitabine / tenofovir df and Ropivacaine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Ropivacaine?

MediHelp rates the interaction as moderate. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Ropivacaine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ropivacaine is metabolized partly by CYP3A4 and CYP1A2, and cobicistat inhibits CYP3A4. Plasma levels may rise modestly, increasing the potential for local anesthetic toxicity with prolonged infusions.

How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Ropivacaine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid prolonged ropivacaine infusions where possible, or reduce the dose and monitor for neurologic and cardiac signs of local anesthetic toxicity.

What other medicines interact with Ropivacaine?

MediHelp also lists interactions of Ropivacaine with, for example, Bupivacaine implant, Bupivacaine liposome, Amlodipine-benazepril. The full list is on the Ropivacaine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in